Global Health Progress

23 March 2010 — The governments of  Italy, the United Kingdom, Canada, Russia, and Norway and the Bill & Melinda Gates Foundation welcome the first long-term agreements made by pharmaceutical firms to supply new, affordable vaccines against pneumococcal disease to the world’s poorest countries.
GlaxoSmithKline (GSK) and Pfizer Inc. are the first companies to agree to [...]

Billions of people worldwide living in developing countries struggle with diseases and other health challenges that threaten their very survival as well as their prospects for building a better life. Developing innovative, sustainable health care solutions for the developing world is essential to ending this vicious cycle of disease, poverty and despair.
The Global Health Progress [...]

Building on success:  new directions in global health
Wednesday March 10, 2010
Highlights

Both The Honorable Bill Clinton and Bill Gates strongly support the Global Health Initiative Bill as the next logical step following PEPFAR.
A strong global public health system is not merely a favor we do for other countries.  It is the right thing to do morally [...]

GlaxoSmithKline (GSK) CEO Andrew Witty today dedicated a new production facility at its Nashik site in India to the manufacture of albendazole, part of a combination treatment used within the World Health Organization’s (WHO) Global Programme to Eliminate Lymphatic Filariasis (LF).

Yesterday, the Ministry of Health (MOH) of Ecuador announced that transmission of onchocerciasis, also known as river blindness, has stopped in that country. This achievement is the result of the work by MOH workers with support of the Onchocerciasis Elimination Program of the Americas (OEPA).